NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NYSE · Medical Distribution · USD

Cencora, Inc. (COR) Stock Analysis

Cencora, Inc. (COR) is a Medical Distribution stock listed on NYSE and quoted in US Dollar.

COR

$330.95

−$6.27 (−1.86%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare COR with… →

COR Key Statistics

As of Sep 4, 2026
Trading
Open
$333.48
Previous Close
$337.22
Day's Range
330.20–336.01
52-Week Range
244.82–377.54
Volume
1.03M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.57
Valuation
Market Cap
$63.15B
P/E Ratio
25.07
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
16.71
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.71
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.19
EPS (ttm)Profit attributable to each share over the last twelve months.
13.20
Financials (FY)
Revenue (FY)
$321.33B+9.31%
Net Income (FY)
$1.55B+2.99%
Profit marginThe share of revenue left as profit after all costs and taxes.
0.79%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
190.83M
1-Year Return
+13.93%
Dividend and dates
Dividend
$2.40+0.71%
Ex-Dividend Date
August 14, 2026
Earnings Date
November 4, 2026
Avg Volume
1.45M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

COR Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−1.43%
2025+51.48%
2024+10.37%
2023+25.33%
2022+26.26%
2021+44.09%
2020+23.37%
2019+23.51%
2018−17.57%
2017+19.51%
2016 (partial year)−11.24%

As of September 4, 2026.

COR Revenue and Earnings by Fiscal Year

FY ends September
Fiscal yearRevenueNet incomeNet margin
2025$321.33B$1.55B0.5%
2024$293.96B$1.51B0.5%
2023$262.17B$1.75B0.7%
2022$238.59B$1.70B0.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$321.33B$11.48B$3.93B$1.55B0.5%
2024$293.96B$9.91B$3.16B$1.51B0.5%
2023$262.17B$8.96B$2.69B$1.75B0.7%
2022$238.59B$8.30B$2.75B$1.70B0.7%

Annual figures as reported, in the company's reporting currency. As of September 30, 2025.

COR Dividend History

$2.25+8.2% vs 2024

Dividends per share, 2025 · 4 payments

YearDividends per sharePaymentsChange
2026*$1.803—
2025$2.254+8.2%
2024$2.084+5.9%
2023$1.974+5.4%
YearDividends per sharePaymentsChange
2026 (partial year)$1.803—
2025$2.254+8.2%
2024$2.084+5.9%
2023$1.974+5.4%
2022$1.874−72.7%
2021$6.828+3.5%
2020$6.598+3.6%
2019$6.368+313.0%
2018$1.544+4.4%
2017$1.484+304.1%
2016$0.371—

Most recent payment: $0.60 per share, ex-dividend August 14, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

COR Valuation vs Medical Distribution Median

Median of 13 stocks
MetricCORMedical Distribution medianvs median
P/E25.0725.783% below
P/S ratio0.190.3647% below
Profit margin0.79%−4.03%4.8 pts above

Medians across 13 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Cencora, Inc. (COR) is capitalised at $63.15B on the latest close. It is classified in the Medical Distribution industry, within the Healthcare sector. Headcount on file is 47,000.

The most recent close on file for COR is $330.95, dated September 4, 2026. That is −$6.27 (−1.86%) against the previous close. Over the past 52 weeks the price has ranged from $244.82 to $377.54. The latest close sits 35.18% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $321.33B. That is +9.31% against the prior fiscal year, when revenue was $293.96B. Net income for the same year was $1.55B. That is +2.99% against the prior fiscal year. Profit margin runs at 0.79%. That is 4.8 percentage points above the Medical Distribution median of −4.03%. Earnings per share on a trailing basis come to 13.2.

Across the 4 fiscal years on file, revenue moves from $238.59B in 2022 to $321.33B in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 25.07. That is 2.75% below the Medical Distribution median of 25.78. On forward earnings the ratio is 16.71. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.71. Measured against sales, the shares trade at 0.19 times revenue. On price-to-sales that is 47.46% below the Medical Distribution median of 0.36. The medians here are taken across 13 Medical Distribution companies that report the metric.

The trailing one-year price return is +13.93%. Across 10 years the annualized return works out at +17.62%. Beta against the wider market is reported at 0.57. Annualized volatility over the trailing 10 years is 27.66%.

Growth & Income

Shareholders receive a dividend, yielding 0.71% on the latest price. The indicated annual rate is $2.40 a share. The ex-dividend date on file is August 14, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $1.80 a share. The year before, 2025, totalled $2.25 a share.

2026 is still running; the price is −1.43% year to date. The strongest complete calendar year on file is 2025 at +51.48%; the weakest is 2018 at −17.57%. Of the 9 complete calendar years on file, 8 finished higher.

Peer Comparison

Cencora, Inc. (COR) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Cencora, Inc. COR $63.15B 25.1
McKesson Corporation MCK $105.86B 24.7
Cardinal Health, Inc. CAH $57.49B 34.4
Henry Schein, Inc. HSIC $10.01B 26.5

The Medical Distribution industry average P/E ratio is 25.8x. Cencora, Inc. trades at a P/E of 25.1.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$105.86B

 CAH

Cardinal Health, Inc.

$57.49B

 HSIC

Henry Schein, Inc.

$10.01B

 AHG

Akso Health Group

$726.49M

 FOCL

EDAP TMS S.A.

$190.70M

 QIPT

Quipt Home Medical Corp

$162.30M
View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Cencora, Inc.

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Visit website →